Sign in / Join Now
ETFs & Funds
Zooming: Cancer focused biotech $
up 36% to $15 in past 8 days. Lots of insider buying but no news propelling the push.
Is that one of the ones rallying on ONXX sympathy?
Could be. Perhaps another potential take over target..?
Add a reply...
Latest StockTalks »
people get INSY breaking news and analysis by email alert.
Get email alerts on INSY »
Insys Therapeutics, Inc.
Get latest price
From other sites
Insys Therapeutics Reports Phase 3 Trial Of Sublingual Buprenorphine Spray Met Primary Endpoint In Patients With Moderate-to-Severe Postoperative Pain After Bunionectomy
at TheStreet (Wed, 6:50AM)
Insys Therapeutics Starts Enrollment in Cannabidiol Trial
at Zacks.com (Fri, 5:32PM)
Insys Therapeutics Announces First Patient Enrolled In Phase II Trial For The Treatment Of Cocaine Dependence Using Pharmaceutical Cannabidiol
at TheStreet (Aug 18, 2016)
Insys Therapeutics Reports Second Quarter 2016 Results
at TheStreet (Aug 3, 2016)
Piper Jaffray On FDA Approval Of Insys Therapeutics' Anorexia Drug Syndros
at Benzinga (Jul 7, 2016)